BioAge Labs (BIOA) Cash from Investing Activities (2024 - 2026)

BioAge Labs (BIOA) has 3 years of Cash from Investing Activities data on file, last reported at -$46.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 40.05% year-over-year to -$46.8 million; the trailing twelve-month figure through Mar 2026 stood at -$64.0 million (up 18.34% YoY), and the FY2025 full-year result was -$95.2 million, down 25915.3% from the prior year.
• Cash from Investing Activities slipped to -$46.8 million in Q1 2026, from -$14.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $12.8 million in Q3 2025 to a low of -$78.0 million in Q1 2025.
• A 3-year average of -$17.8 million and a median of -$7.4 million in 2024 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 4310.16% in 2025, while the deepest fall reached 55392.31% in 2025.
• Tracing BIOA's Cash from Investing Activities over 3 years: stood at -$26000.0 in 2024, then sank by 55392.31% to -$14.4 million in 2025, then plunged by 224.04% to -$46.8 million in 2026.
• Business Quant data shows BIOA's Cash from Investing Activities at -$46.8 million in Q1 2026, -$14.4 million in Q4 2025, and $12.8 million in Q3 2025.